Teva Pharmaceutical Industries Ltd. (TEVA)
30.18
+0.38
(+1.28%)
USD |
NYSE |
Dec 11, 16:00
30.19
+0.01
(+0.03%)
After-Hours: 20:00
Teva Pharmaceutical Industries Shareholders Equity (Quarterly): 7.250B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen, Inc. | 9.619B |
| Novo Nordisk A/S | 26.74B |
| Can-Fite BioPharma Ltd. | -- |
| BiomX, Inc. | 10.49M |
| Nasus Pharma Ltd. | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 39.86B |
| Total Liabilities (Quarterly) | 32.60B |
| Debt to Equity Ratio | 2.355 |
| Current Ratio | 1.108 |
| Net Debt Paydown Yield | 1.60% |